Cargando…
Clinical value of carcinoembryonic antigen for predicting the incidence of brain metastases and survival in small cell lung cancer patients treated with prophylactic cranial irradiation
BACKGROUND: Although the role of prophylactic cranial irradiation (PCI) in the treatment of small cell lung cancer (SCLC) has been confirmed, the occurrence of brain metastases (BM) in patients remains a major problem. We designed this study to evaluate the clinical value of carcinoembryonic antigen...
Autores principales: | Guo, Dong, Jing, Wang, Zhu, Hui, Li, Minghuan, Zou, Bing, Zhang, Yan, Fu, Lei, Kong, Li, Yue, Jinbo, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130305/ https://www.ncbi.nlm.nih.gov/pubmed/30233236 http://dx.doi.org/10.2147/CMAR.S175043 |
Ejemplares similares
-
Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
por: Zhu, Hui, et al.
Publicado: (2014) -
Risk factors for brain metastases after prophylactic cranial irradiation in small cell lung cancer
por: Zeng, Haiyan, et al.
Publicado: (2017) -
Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021) -
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
por: Witlox, Willem J. A., et al.
Publicado: (2018) -
Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer
por: Fan, Xinyu, et al.
Publicado: (2023)